Drug Profile
Aldesleukin biosimilar - Amega Biotech
Alternative Names: IL-2 - Amega Biotech; Recombinant interleukin 2 biosimilar - Amega Biotech; Recombinant interleukin-2 - Amega BiotechLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Amega Biotech
- Class Antiallergics; Antihyperglycaemics; Antineoplastics; Immunotherapies; Interleukins; Mood stabilisers; Recombinant proteins
- Mechanism of Action Immunostimulants; Interleukin-2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Malignant melanoma; Renal cancer
Most Recent Events
- 15 Aug 2013 Investigation in Malignant melanoma in Argentina (Parenteral)
- 15 Aug 2013 Investigation in Renal cancer in Argentina (Parenteral)